Cargando…
Differences in the Microbial Composition of Hemodialysis Patients Treated with and without β-Blockers
β-blockers are commonly prescribed to treat cardiovascular disease in hemodialysis patients. Beyond the pharmacological effects, β-blockers have potential impacts on gut microbiota, but no study has investigated the effect in hemodialysis patients. Hence, we aim to investigate the gut microbiota com...
Autores principales: | Lin, Yi-Ting, Lin, Ting-Yun, Hung, Szu-Chun, Liu, Po-Yu, Hung, Wei-Chun, Tsai, Wei-Chung, Tsai, Yi-Chun, Delicano, Rachel Ann, Chuang, Yun-Shiuan, Kuo, Mei-Chuan, Chiu, Yi-Wen, Wu, Ping-Hsun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002078/ https://www.ncbi.nlm.nih.gov/pubmed/33809103 http://dx.doi.org/10.3390/jpm11030198 |
Ejemplares similares
-
Anti-Acid Drug Treatment Induces Changes in the Gut Microbiome Composition of Hemodialysis Patients
por: Lin, Yi-Ting, et al.
Publicado: (2021) -
Comparative Gut Microbiome Differences between Ferric Citrate and Calcium Carbonate Phosphate Binders in Patients with End-Stage Kidney Disease
por: Wu, Ping-Hsun, et al.
Publicado: (2020) -
Gut dysbiosis and mortality in hemodialysis patients
por: Lin, Ting-Yun, et al.
Publicado: (2021) -
Association of malnutrition with SARS-CoV-2 vaccine response in patients undergoing hemodialysis
por: Lin, Ting-Yun, et al.
Publicado: (2022) -
Association between Circulation Indole-3-Acetic Acid Levels and Stem Cell Factor in Maintenance Hemodialysis Patients: A Cross-Sectional Study
por: Wu, Ping-Hsun, et al.
Publicado: (2020)